Overview

Low-dose Hydrocortisone in Acutely Burned Patients

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Major burns trigger the release of circulating mediators, as cytokines and endotoxin that induces a systemic inflammatory response syndrome. The cardiovascular effects are similar to those seen in septic shock. After the initial hypovolemic phase, patients with extensive burns often present a shock with increased cardiac output and reduced systemic vascular resistances. As described in septic shock, we test the hypothesis that low-dose hydrocortisone could decrease the duration of the shock period.
Phase:
Phase 4
Details
Lead Sponsor:
Hospices Civils de Lyon
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate